Internal Medicine, Infectious Disease · Birmingham, AL
NPI
1245258573
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
833 Saint Vincents Dr Ste 300
Birmingham, AL, 35205
Phone (205) 933-4640
Groups this clinician bills Medicare through
Medicare paid, 2024
$76K
2,091 services
Medicare patients, 2024
216
Average age 74
Drug cost, 2024
$942K
1,432 prescriptions
Company payments, 2025
$357
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Leland N Allen III was code 99232 (hospital e&m - subsequent), 637 times for 128 patients. In total Leland N Allen III billed 2,091 services in 43 codes, and Medicare paid $76K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 637 | 128 | $57.10 | $36K |
| 99223 Hospital E&M - Initial | Facility | 95 | 90 | $125.31 | $12K |
| 99214 Office E&M - Established | Office | 83 | 53 | $84.15 | $6,984 |
| 85025 Blood Count | Office | 74 | 41 | $7.11 | $526 |
| 85652 Clinical Chemistry | Office | 64 | 37 | $2.49 | $160 |
| 86140 Clinical Chemistry | Office | 63 | 36 | $4.77 | $300 |
| 36415 Venipuncture Blood Collection | Office | 60 | 37 | $8.65 | $519 |
| 80048 Clinical Chemistry | Office | 60 | 35 | $7.60 | $456 |
| 99233 Hospital E&M - Subsequent | Facility | 54 | 15 | $86.16 | $4,652 |
| 99213 Office E&M - Established | Office | 50 | 40 | $56.03 | $2,802 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 49 | 34 | $11.04 | $541 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 14 | 13 | $38.33 | $537 |
By year: 2022 $119K for 2,221 services; 2023 $75K for 2,314 services; 2024 $76K for 2,091 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 74 | 41 | $7.11 | $526 |
| 85652 Clinical Chemistry | 64 | 37 | $2.49 | $160 |
| 86140 Clinical Chemistry | 63 | 36 | $4.77 | $300 |
| 36415 Venipuncture Blood Collection | 60 | 37 | $8.65 | $519 |
| 80048 Clinical Chemistry | 60 | 35 | $7.60 | $456 |
Medicare prescription drug claims, 2024
In 2024, the drug Leland N Allen III prescribed most often to Medicare patients was Ceftriaxone (Ceftriaxone Sodium), with 168 prescriptions and refills. In total Leland N Allen III wrote 1,432 Medicare prescriptions that cost $942K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ceftriaxone Ceftriaxone Sodium | 168 | 168 | 36 | $20K |
| Cephalexin Generic | 134 | 203 | 36 | $7,267 |
| Vancomycin Hcl Generic | 113 | 113 | 31 | $13K |
| Daptomycin Generic | 103 | 103 | 21 | $98K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 80 | 88 | 12 | $356K |
| Levofloxacin Generic | 72 | 114 | 29 | $1,455 |
| Doxycycline Hyclate Generic | 66 | 86 | 23 | $2,966 |
| Clindamycin Hcl Generic | 62 | 88 | 20 | $2,379 |
| Cefazolin Sodium Generic | 62 | 62 | 15 | $3,659 |
| Amoxicillin Generic | 53 | 79 | 16 | $430 |
| Fluconazole Generic | 41 | 41 | 12 | $2,302 |
| Nafcillin Sodium Generic | 30 | 30 | Under 11 | $19K |
| Azithromycin Generic | 29 | 29 | 16 | $251 |
| Ethambutol Hcl Generic | 26 | 26 | Under 11 | $772 |
| Ertapenem Ertapenem Sodium | 25 | 25 | 12 | $14K |
Brand drugs: 232 claims; generic drugs: 1,200 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Leland N Allen III $357 ($357 in general payments such as food, travel and fees) from 7 companies. The largest payer was La Jolla Pharmaceutical Company with $109.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.